Hasil Pencarian - Kiran Kumar Rathinam

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review

    Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review oleh Kiran Kumar Rathinam, PharmD, Justin Jacob Abraham, PharmD, Thangavel Mahalingam Vijayakumar, PhD

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19

    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19 oleh I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Justin Jacob Abraham, Muhasaparur Ganesan Rajanandh, Thangavel Mahalingam Vijayakumar

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19

    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19 oleh Justin Jacob Abraham, I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Muhasaparur Ganesan Rajanandh, Vijayakumar Thangavel Mahalingam

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial

    Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial oleh Karthickeyan Krishnan, Muthuraj K, Nandhini K, Yalamanchili Dharma Teja, Vikrama Simha Reddy, Neethu Sara Raju, Kiran Kumar Rathinam

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: